Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
tiotropium 18 mcg
Boehringer Ingelheim
Pulmonary Disease, Chronic Obstructive
1 trial -
turoctocog alfa
Novo Nordisk A/S
Congenital Bleeding Disorder
2 trials -
5-gene classification model
Hospital Authority, Hong Kong
ABO Blood Type Incompatible Kidney Transplantation
1 trial -
A continuous intravenous infusion of 0.5-0.6 mg/kg/h Rocuronium Bromide Intravenous Solution (50 Mg/5 mL) to keep the target neuromuscular blockade (PTC = 1-2).
The First People's Hospital of Lianyungang
Neuromuscular Blockade
1 trial -
A single dose of liposomal bupivacaine is administered at the conclusion of surgery without adjunctive analgesics, followed by a supplemental dose 72 hours postoperatively.
The First People's Hospital of Lianyungang
Anal Fistula
1 trial -
AREG-TRIGGER
Hospital Authority, Hong Kong
PCOS
1 trial -
Accurate Prediction Artificial Intelligence Models
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Anti-PD1
Hospital Authority, Hong Kong
Nasopharyngeal Carcinoma (NPC)
1 trial -
Anvitra Gastric Suspension
Hong Kong Baptist University
GERD (Heartburn, Regurgitation, and Dyspepsia) Frequency
1 trial -
Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm
The First People's Hospital of Lianyungang
Ovarian Cancer
1 trial -
Artificial intelligence
Hospital Authority, Hong Kong
Internal Disease
1 trial -
Artificial intelligence in diagnosis
Prime Medicine
Artificial Intelligence (AI) in Diagnosis
1 trial -
Artificial intelligence-assisted chest X-ray in TB screening
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Tuberculosis (TB)
1 trial -
Aspirin
Regeneron UK Limited
Healthy Volunteer
1 trial -
Best medical management
The First People's Hospital of Lianyungang
Stroke, Ischemic
1 trial -
Betaine
Ultragenyx UK Limited
Angelman Syndrome
1 trial -
Beverage powder fortified with micronutrients and Bacopa monnieri extract
COGNITION THERAPEUTICS INC
Cognition
1 trial -
Biobanking with genetic analysis
Chongqing Precision Biotech Co., Ltd
Chronic Inflammatory Disease
1 trial -
Biobran supplementation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer Stages I
1 trial -
Blood sample
Ultragenyx UK Limited
Amelogenesis Imperfecta
1 trial -
CYP2C19 genotype testing
Beijing Anzhen Hospital
Angina, Stable
1 trial -
Cadonilimab
The First People's Hospital of Lianyungang
Locally Advanced Esophageal Squamous Cell Carcinoma
1 trial -
Cambridge Weight Plan
United Therapeutics Europe Ltd
Diabetes
1 trial -
Carrelizumab
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources